Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nashimoto

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Nihon Geka Gakkai Zasshi|November 1, 1988
[Clinicopathological study of early gastric cancer--indication of conservative surgery and radical endoscopic treatment of early gastric cancer]A Nashimoto, S Tanaka, K Miyashita, et al.
The British Journal of Surgery|March 27, 2014
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasisA Tsuburaya, J Mizusawa, Y Tanaka, et al.
The British Journal of Surgery|August 18, 2005
Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancerY Kodera, M Sasako, S Yamamoto, et al.
Surgery Today|January 1, 1997
Disease-free survival for 6 years and 4 months after dissection of recurrent abdominal paraaortic nodes (no. 16) in gastric cancer: report of a caseA Nashimoto, J Sasaki, M Sano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 15, 1998
[Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer]A Nashimoto, Y Tsuchiya, J Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 3, 2000
[A patient with advanced gastric cancer who obtained downstaging and underwent radical surgery by neoadjuvant chemotherapy]M Kawahara, A Nashimoto, H Yabusaki, et al.
Lancet (London, England)|August 10, 1999
Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study GroupT Nakajima, A Nashimoto, M Kitamura, et al.
Cancer|August 16, 2001
Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survivalT Kawamura, T Kusakabe, T Sugino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1992
[Borrmann 4 gastric cancer treated with l-LV and 5-FU combination--a case report]T Kato, Y Saito, M Niwa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma]T Kato, M Niwa, Y Saito, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Nihon Geka Gakkai Zasshi|November 1, 1988
[Clinicopathological study of early gastric cancer--indication of conservative surgery and radical endoscopic treatment of early gastric cancer]A Nashimoto, S Tanaka, K Miyashita, et al.
The British Journal of Surgery|March 27, 2014
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasisA Tsuburaya, J Mizusawa, Y Tanaka, et al.
The British Journal of Surgery|August 18, 2005
Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancerY Kodera, M Sasako, S Yamamoto, et al.
Surgery Today|January 1, 1997
Disease-free survival for 6 years and 4 months after dissection of recurrent abdominal paraaortic nodes (no. 16) in gastric cancer: report of a caseA Nashimoto, J Sasaki, M Sano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 15, 1998
[Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer]A Nashimoto, Y Tsuchiya, J Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 3, 2000
[A patient with advanced gastric cancer who obtained downstaging and underwent radical surgery by neoadjuvant chemotherapy]M Kawahara, A Nashimoto, H Yabusaki, et al.
Lancet (London, England)|August 10, 1999
Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study GroupT Nakajima, A Nashimoto, M Kitamura, et al.
Cancer|August 16, 2001
Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survivalT Kawamura, T Kusakabe, T Sugino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1992
[Borrmann 4 gastric cancer treated with l-LV and 5-FU combination--a case report]T Kato, Y Saito, M Niwa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma]T Kato, M Niwa, Y Saito, et al.
Pageof 4